| Filed 2021-03-04 18:52 Tx date 2021-03-04 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $19,000
+50,000 vol
$0.38 each | 1,946,500 | |
| Filed 2021-03-04 18:51 Tx date 2021-03-04 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $4,000
+10,000 vol
$0.40 each | 1,896,500 | |
| Filed 2021-03-04 18:50 Tx date 2021-03-04 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $15,800
+40,000 vol
$0.395 each | 1,886,500 | |
| Filed 2021-03-04 18:49 Tx date 2021-03-04 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $4,000
+10,000 vol
$0.40 each | | |
| Filed 2021-03-04 18:49 Tx date 2021-03-04 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $9,875
+25,000 vol
$0.395 each | | |
| Filed 2021-03-04 18:48 Tx date 2021-03-04 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $4,000
+10,000 vol
$0.40 each | | |
| Filed 2021-03-04 18:47 Tx date 2021-03-04 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $9,875
+25,000 vol
$0.395 each | | |
| Filed 2021-03-03 16:15 Tx date 2021-03-03 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $6,675
+15,000 vol
$0.445 each | 1,846,500 | |
| Filed 2021-03-03 16:15 Tx date 2021-03-03 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $9,000
+20,000 vol
$0.45 each | 1,831,500 | |
| Filed 2021-03-03 16:14 Tx date 2021-03-03 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $11,000
+25,000 vol
$0.44 each | 1,811,500 | |
| Filed 2021-03-02 14:12 Tx date 2021-03-02 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $19,000
+40,000 vol
$0.475 each | 1,786,500 | |
| Filed 2021-02-23 12:25 Tx date 2021-02-18 | $RVV
Revive Therapeutics Ltd. | Jackson, William 4 - Director of Issuer Direct Ownership | Common Shares 51 - Exercise of options | $14,000
+200,000 vol
$0.07 each | 200,000 | |
| Filed 2021-02-23 12:24 Tx date 2021-02-18 | $RVV
Revive Therapeutics Ltd. | Jackson, William 4 - Director of Issuer Direct Ownership | Options 51 - Exercise of options |
-200,000 vol | 700,000 | |